We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Ultrasound Technology Improves Diagnostics in Women’s Healthcare

By HospiMedica International staff writers
Posted on 10 Oct 2011
A series of new ultrasound enhancements are designed to increase diagnostic effectiveness in women’s healthcare.

GE Healthcare (Chalfont St. More...
Giles, UK) announced the availability of HDlive and Volume SRI (speckle reduction imaging) for women’s health imaging products within its Voluson Expert series platform. These innovations were presented for the first time in the United States at the 2011 International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) congress in Los Angeles, CA, USA, in September 2011.

HDlive is one of the new key rendering tools on the new dynamic rendering engine on the Expert Series platform. This tool provides exceptional anatomic realism and helps increase depth perception. This novel imaging capability can help medical professionals achieve a deeper understanding of relational anatomy, help enhance diagnostic effectiveness, and ultimately improve patient communication. This is available on the Voluson E8 and E8 Expert.

Instead of single slice imaging, Volume SRI utilizes volumetric, multiplane imaging to enhance the speckle reduction in clinical images. The tool helps improve three-dimensional (3D)/4D image quality in multiplanar studies and rendered mode, and also provides an enhanced smoothing effect on rendered images.

“The imaging potential of these latest GE Healthcare innovations is unlike anything we’ve developed in the past,” said Karl-Heinz Lumpi, general manager of women’s health ultrasound for GE Healthcare. “Through the HDlive and Volume SRI technologies, we intend to make advanced women’s health imaging through ultrasound more prevalent and accessible. These technologies have the potential enables better diagnosis for more patients around the world.”

Complementing the latest hardware additions to the Voluson Expert series new advanced transducer technology. Optimized for ob/gyn purposes, the following 2D and 3D/4D probes enable quality images across a wide range of general and specialized exams. With the RAB6-D new ultra-light volume transducer, user fatigue is not a problem. GE Healthcare’s next-generation volume transducer, which is 40% lighter than the previous version, has an ergonomic design that provides excellent image quality in 2D and 3D/4D, while sitting comfortably in the operator’s hand. The C4-8-D new wideband transducer’s high frequency and small footprint helps provide high-resolution obstetrical images during each trimester.

Related Links:
GE Healthcare



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Blood Gas Analyzer
i-Check200
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.